In subtle and not-so-subtle ways, today’s bioeconomy touches nearly every aspect of our lives. And new technologies and ...
Novartis will launch a direct-to-patient (DTP) platform in the US on November 1, 2025, starting with Cosentyx, which will be offered at a 55% dis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback